NuCana Plc (NCNA)
0.9853
+0.03
(+2.64%)
USD |
NASDAQ |
Oct 23, 16:00
0.985
0.00 (0.00%)
After-Hours: 20:00
NuCana Enterprise Value : -20.75M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -20.75M |
| October 22, 2026 | -20.86M |
| October 21, 2026 | -20.85M |
| October 20, 2026 | -20.66M |
| October 19, 2026 | -20.78M |
| October 16, 2026 | -20.73M |
| October 15, 2026 | -20.60M |
| October 14, 2026 | -20.47M |
| October 13, 2026 | -20.47M |
| October 12, 2026 | -20.34M |
| October 09, 2026 | -20.25M |
| October 08, 2026 | -20.12M |
| October 07, 2026 | -20.08M |
| October 06, 2026 | -20.30M |
| October 05, 2026 | -20.43M |
| October 02, 2026 | -20.30M |
| October 01, 2026 | -19.95M |
| September 30, 2026 | -19.18M |
| September 29, 2026 | -19.78M |
| September 28, 2026 | -19.43M |
| September 25, 2026 | -19.48M |
| September 24, 2026 | -19.30M |
| September 23, 2026 | -19.35M |
| September 22, 2026 | -19.26M |
| September 21, 2026 | -19.30M |
| Date | Value |
|---|---|
| September 18, 2026 | -19.22M |
| September 17, 2026 | -19.26M |
| September 16, 2026 | -19.39M |
| September 15, 2026 | -19.39M |
| September 14, 2026 | -19.30M |
| September 11, 2026 | -19.30M |
| September 10, 2026 | -19.22M |
| September 09, 2026 | -19.09M |
| September 08, 2026 | -18.96M |
| September 04, 2026 | -18.96M |
| September 03, 2026 | -18.83M |
| September 02, 2026 | -19.00M |
| September 01, 2026 | -19.05M |
| August 31, 2026 | -18.66M |
| August 28, 2026 | -17.41M |
| August 27, 2026 | -18.66M |
| August 26, 2026 | -18.40M |
| August 25, 2026 | -18.66M |
| August 24, 2026 | -18.66M |
| August 21, 2026 | -18.44M |
| August 20, 2026 | -18.40M |
| August 19, 2026 | -18.31M |
| August 18, 2026 | -18.44M |
| August 17, 2026 | -18.31M |
| August 14, 2026 | -18.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 15.88M |
| BioNTech SE | 5.602B |
| Silence Therapeutics Plc | 830.94M |
| Autolus Therapeutics Plc | 574.58M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.134M |
| Total Expenses (Quarterly) | 4.134M |
| EPS Diluted (Quarterly) | -1.007 |
| Earnings Yield | -326.8% |
| Normalized Earnings Yield | -318.23 |